The amount of expense arising from cash-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_ExpenseFromCashsettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of liabilities arising from share-based payment transactions. Share-based payment transactions are transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 51
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_b_i&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Restricted Stock -Unit Plans [Line Items]

+ References

No definition available.

+ Details

Name:	mor_RestrictedStockUnitPlansLineItems
Namespace Prefix:	mor_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Target Achievement

+ References

No definition available.

+ Details

Name:	mor_TargetAchievement
Namespace Prefix:	mor_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	ifrs-full_ComponentsOfEquityAxis=ifrs-full_AdditionalPaidinCapitalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mor_A2020AprilRestrictedStockUnitPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mor_A2020OctoberRestrictedStockUnitPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

RS - Summary of cash-settled 2020 Restricted Stock Unit Plan (Details) - EUR (€)		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Apr. 01, 2021
Restricted Stock Unit Plans [Line Items]
Expenses through Share-based Payment Transactions and Issue of Convertible Instruments		€ (5,940,339)	€ (1,022,786)	€ (2,587,931)
Additional Paid-in Capital
Restricted Stock Unit Plans [Line Items]
Expenses through Share-based Payment Transactions and Issue of Convertible Instruments	€ 246,265	(5,940,339)	(1,022,786)	(2,587,931)
MorphoSys US Inc. – April 2020 Restricted Stock Unit Plan
Restricted Stock Unit Plans [Line Items]
Target achievement					49.00%
Liabilities from share-based payment transactions		290,378
Expense from cash-settled share-based payment transactions		(28,242)	€ (1,074,075)	€ (462,243)
MorphoSys US Inc. – October 2020 Restricted Stock Unit Plan
Restricted Stock Unit Plans [Line Items]
Target achievement	71.00%
Liabilities from share-based payment transactions		€ 61,364